Zydus seeks DCGI approval for using PegIFN in COVID-19 treatment
91.15% of patients treated with PegIFN were RT PCR negative by day 7 as compared to 78.90% on the standard of care (SOC) arm
Source: biospectrumindia.com
Pegihep Peg News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pegihep Peg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pegihep Peg Today - Breaking & Trending Today
Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
Source: aninews.in